Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited)

v2.4.0.8
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited) (USD $)
 3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Revenue:        
PCT products, services, other $ 327,958 $ 297,867 $ 746,050 $ 687,023
Grant revenue 92,804 93,749 403,186 335,162
Total revenue 420,762 391,616 1,149,236 1,022,185
Costs and expenses:        
Cost of PCT products and services 175,995 108,689 364,368 296,086
Research and development 280,276 247,717 787,142 775,635
Selling and marketing 190,882 164,313 573,174 570,578
General and administrative 617,642 557,417 1,851,634 1,713,778
Total operating costs and expenses 1,264,795 1,078,136 3,576,318 3,356,077
Operating loss (844,033) (686,520) (2,427,082) (2,333,892)
Other (expense) income:        
Interest (expense) income,net (158,162) (10,540) (230,176) (71,067)
Other (expense) (2,132)    (210,838)   
Change in fair value of warrant derivative liability 331,113 (98,978) 349,472 36,322
Total other (expense) income 170,819 (109,518) (91,542) (34,745)
Net loss (673,214) (796,038) (2,518,624) (2,368,637)
Accrued dividends on convertible preferred stock (42,938) (129,789) (765,530) (895,734)
Net loss applicable to common shareholders $ (716,152) $ (925,827) $ (3,284,154) $ (3,264,371)
Net loss per share attributable to common stockholders - basic and diluted $ (0.06) $ (0.09) $ (0.28) $ (0.34)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 11,664,484 10,872,877 11,776,740 9,598,066